Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18837738 [patent_doc_number] => 11845801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-19 [patent_title] => IL-15 prodrugs and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/900677 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 36 [patent_no_of_words] => 18813 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900677 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/900677
IL-15 prodrugs and methods of use thereof Jun 11, 2020 Issued
Array ( [id] => 16328423 [patent_doc_number] => 20200299389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => Bifunctional Proteins Combining Checkpoint Blockade for Targeted Therapy [patent_app_type] => utility [patent_app_number] => 16/896597 [patent_app_country] => US [patent_app_date] => 2020-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9314 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16896597 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/896597
Bifunctional proteins combining checkpoint blockade for targeted therapy Jun 8, 2020 Issued
Array ( [id] => 16539462 [patent_doc_number] => 20200405875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => CKIT ANTIBODY DRUG CONJUGATES [patent_app_type] => utility [patent_app_number] => 16/893359 [patent_app_country] => US [patent_app_date] => 2020-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44680 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16893359 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/893359
CKIT antibody drug conjugates Jun 3, 2020 Issued
Array ( [id] => 16310894 [patent_doc_number] => 20200289632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS [patent_app_type] => utility [patent_app_number] => 16/887815 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35184 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887815 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/887815
A*03 restricted peptides for use in immunotherapy against cancers and related methods May 28, 2020 Issued
Array ( [id] => 16312350 [patent_doc_number] => 20200291088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS [patent_app_type] => utility [patent_app_number] => 16/887994 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52059 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887994 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/887994
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers May 28, 2020 Issued
Array ( [id] => 16507502 [patent_doc_number] => 20200386758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => GDF-15 AS A DIAGNOSTIC MARKER FOR MELANOMA [patent_app_type] => utility [patent_app_number] => 16/876482 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27192 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876482 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/876482
GDF-15 AS A DIAGNOSTIC MARKER FOR MELANOMA May 17, 2020 Abandoned
Array ( [id] => 17704637 [patent_doc_number] => 20220204643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/606246 [patent_app_country] => US [patent_app_date] => 2020-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 374540 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -99 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606246 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/606246
Cancer associated antibody compositions and methods of use Apr 28, 2020 Issued
Array ( [id] => 17867119 [patent_doc_number] => 20220289854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => METHODS FOR TREATING CANCER USING COMBINATIONS OF ANTI-CX3CR1 AND IMMUNE CHECKPOINT BLOCKADE AGENTS [patent_app_type] => utility [patent_app_number] => 17/606585 [patent_app_country] => US [patent_app_date] => 2020-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66320 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -62 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606585 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/606585
METHODS FOR TREATING CANCER USING COMBINATIONS OF ANTI-CX3CR1 AND IMMUNE CHECKPOINT BLOCKADE AGENTS Apr 23, 2020 Pending
Array ( [id] => 17112113 [patent_doc_number] => 20210292710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => METHOD FOR ENHANCING IMMUNE FUNCTION OF IMMUNE CELL AND IMMUNE CELL LINE PRODUCED USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/833011 [patent_app_country] => US [patent_app_date] => 2020-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11734 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16833011 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/833011
METHOD FOR ENHANCING IMMUNE FUNCTION OF IMMUNE CELL AND IMMUNE CELL LINE PRODUCED USING THE SAME Mar 26, 2020 Abandoned
Array ( [id] => 16507505 [patent_doc_number] => 20200386761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => SPECIFIC BIOMARKER SET FOR NON-INVASIVE DIAGNOSIS OF LIVER CANCER [patent_app_type] => utility [patent_app_number] => 16/825515 [patent_app_country] => US [patent_app_date] => 2020-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825515 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/825515
SPECIFIC BIOMARKER SET FOR NON-INVASIVE DIAGNOSIS OF LIVER CANCER Mar 19, 2020 Abandoned
Array ( [id] => 16328438 [patent_doc_number] => 20200299404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => Method for providing personalized cells with chimeric antigen receptors (CAR) [patent_app_type] => utility [patent_app_number] => 16/823012 [patent_app_country] => US [patent_app_date] => 2020-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5871 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823012 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/823012
Method for providing personalized cells with chimeric antigen receptors (CAR) Mar 17, 2020 Pending
Array ( [id] => 16614959 [patent_doc_number] => 20210033612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => METHODS OF USING NON-RARE CELLS TO DETECT RARE CELLS [patent_app_type] => utility [patent_app_number] => 16/819684 [patent_app_country] => US [patent_app_date] => 2020-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14586 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16819684 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/819684
METHODS OF USING NON-RARE CELLS TO DETECT RARE CELLS Mar 15, 2020 Abandoned
Array ( [id] => 16087085 [patent_doc_number] => 20200197529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => ANTIGEN BINDING PROTEINS [patent_app_type] => utility [patent_app_number] => 16/815677 [patent_app_country] => US [patent_app_date] => 2020-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32272 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16815677 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/815677
Antigen binding proteins Mar 10, 2020 Issued
Array ( [id] => 16284748 [patent_doc_number] => 20200278350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => COMPOSITIONS AND METHODS FOR DETERMIINNG CANCER PROGNOSIS [patent_app_type] => utility [patent_app_number] => 16/805464 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805464 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/805464
Compositions and methods for determining cancer prognosis Feb 27, 2020 Issued
Array ( [id] => 16756610 [patent_doc_number] => 10975147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Modified J-chain [patent_app_type] => utility [patent_app_number] => 16/803745 [patent_app_country] => US [patent_app_date] => 2020-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 19 [patent_no_of_words] => 17063 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16803745 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/803745
Modified J-chain Feb 26, 2020 Issued
Array ( [id] => 18289907 [patent_doc_number] => 11618770 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-04 [patent_title] => MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same [patent_app_type] => utility [patent_app_number] => 16/795391 [patent_app_country] => US [patent_app_date] => 2020-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6851 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795391 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/795391
MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same Feb 18, 2020 Issued
Array ( [id] => 17625875 [patent_doc_number] => 20220160890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => SURVIVAL-TARGETING CHIMERIC (SURTAC) MOLECULES [patent_app_type] => utility [patent_app_number] => 17/426141 [patent_app_country] => US [patent_app_date] => 2020-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18966 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426141 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/426141
SURVIVAL-TARGETING CHIMERIC (SURTAC) MOLECULES Feb 18, 2020 Pending
Array ( [id] => 15993511 [patent_doc_number] => 20200172626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => ANTI-HUMAN 4-1BB ANTIBODIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/790299 [patent_app_country] => US [patent_app_date] => 2020-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32196 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790299 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/790299
Anti-human 4-1BB antibodies and uses thereof Feb 12, 2020 Issued
Array ( [id] => 16141465 [patent_doc_number] => 10703795 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers [patent_app_type] => utility [patent_app_number] => 16/778915 [patent_app_country] => US [patent_app_date] => 2020-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 31 [patent_no_of_words] => 53002 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16778915 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/778915
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers Jan 30, 2020 Issued
Array ( [id] => 17482270 [patent_doc_number] => 20220089774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO CCSP-2 AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/310296 [patent_app_country] => US [patent_app_date] => 2020-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12183 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 324 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310296 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/310296
Monoclonal antibody specifically binding to CCSP-2 and use thereof Jan 28, 2020 Issued
Menu